FDA action counts
| Total FDA actions | 1 |
|---|---|
| Warning letters | 1 |
| Recalls | 0 |
| Approval records | 0 |
| Form 483 inspection citations | 0 |
| Most recent action | August 6, 2026 |
Enforcement history
On 2026-08-06, Argus HQ recorded an FDA Warning Letter for Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd., rated "high" severity in Argus HQ's classification: Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd. — CGMP/Active Pharmaceutical Ingredient (API)/Adulterated/Misbranded (2026-08-06). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.
Risk pattern analysis
Argus HQ analysis — not an FDA finding
This section is Argus HQ analysis, not an FDA finding. Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd. has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Frequently asked questions
- How many FDA actions does Argus HQ track for Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd.?
- 1 total: 1 warning letter, 0 recalls, 0 approval records, and 0 Form 483 inspection citations.
- What is the most recent FDA action on file for Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd.?
- August 6, 2026. Argus HQ ingests new FDA enforcement records daily.
- Has Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd. received FDA warning letters?
- Yes, 1 warning letter on file. See the full history below for each one.
- Is this FDA enforcement data for Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd. official?
- Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.
Every FDA action tied to this company, the week it happens.
Free weekly briefing. Real-time alerts on paid plans.
Related enforcement actions
Compare with
- Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd. vs Philips North America
- Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd. vs Medline Industries, LP
- Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd. vs Boston Scientific Corporation
- Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd. vs Baxter Healthcare Corporation
- Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd. vs PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Verified from FDA.gov · Last updated: Aug 6, 2026Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd.'s Complete FDA Record. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/company/tianjin-kilo-pharmaceutical-sci-tech-co-ltd
"Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd.'s Complete FDA Record." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/company/tianjin-kilo-pharmaceutical-sci-tech-co-ltd.
Argus HQ Research. "Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd.'s Complete FDA Record." Digital Empire Holdings LLC. Accessed August 19, 2026. https://argushq.ai/company/tianjin-kilo-pharmaceutical-sci-tech-co-ltd.
@misc{argushq_argushq_ai_company_tianjin_kilo_pharmaceutical_sci_tech_co_ltd_2026,
title = {Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd.'s Complete FDA Record},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/company/tianjin-kilo-pharmaceutical-sci-tech-co-ltd},
note = {Accessed: August 19, 2026}
}Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗